CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia
Abdulfatah M. Alayoubi, Zakaria Yahya Khawaji, Mohammed A. Mohammed, François Mercier
Topics & Concepts
CRISPRChimeric antigen receptorGenome editingCas9Genetic enhancementHematologyLeukemiaMedicineImmunotherapyCancerComputational biologyCancer researchImmunologyBioinformaticsBiologyGeneInternal medicineGeneticsCRISPR and Genetic EngineeringCAR-T cell therapy research